[go: up one dir, main page]

FI102169B1 - 3-aminopyrrolit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina - Google Patents

3-aminopyrrolit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina

Info

Publication number
FI102169B1
FI102169B1 FI905689A FI905689A FI102169B1 FI 102169 B1 FI102169 B1 FI 102169B1 FI 905689 A FI905689 A FI 905689A FI 905689 A FI905689 A FI 905689A FI 102169 B1 FI102169 B1 FI 102169B1
Authority
FI
Finland
Prior art keywords
aminopyrrols
drugs
processes
preparation
Prior art date
Application number
FI905689A
Other languages
English (en)
Swedish (sv)
Other versions
FI905689L (fi
FI905689A0 (fi
FI102169B (fi
Inventor
Juergen Liebscher
Alexander Knoll
Alexej Uschmajew
Andreas Rolfs
Dieter Lohmann
Gottfried Faust
Eveline Morgenstern
Peter Scharfenberg
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of FI905689A0 publication Critical patent/FI905689A0/fi
Publication of FI905689L publication Critical patent/FI905689L/fi
Application granted granted Critical
Publication of FI102169B1 publication Critical patent/FI102169B1/fi
Publication of FI102169B publication Critical patent/FI102169B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI905689A 1989-11-17 1990-11-16 3-aminopyrrolit, menetelmä niiden valmistamiseksi ja niiden käyttö lää keaineina FI102169B (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD89334670A DD298912A5 (de) 1989-11-17 1989-11-17 Verfahren zur herstellung von 3-aminopyrrolen

Publications (4)

Publication Number Publication Date
FI905689A0 FI905689A0 (fi) 1990-11-16
FI905689L FI905689L (fi) 1991-05-18
FI102169B1 true FI102169B1 (fi) 1998-10-30
FI102169B FI102169B (fi) 1998-10-30

Family

ID=5613902

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905689A FI102169B (fi) 1989-11-17 1990-11-16 3-aminopyrrolit, menetelmä niiden valmistamiseksi ja niiden käyttö lää keaineina

Country Status (10)

Country Link
US (2) US5502051A (fi)
EP (1) EP0431371B1 (fi)
JP (1) JPH07113015B2 (fi)
DD (1) DD298912A5 (fi)
DE (1) DE59010759D1 (fi)
ES (1) ES2108005T3 (fi)
FI (1) FI102169B (fi)
HU (1) HUT56343A (fi)
RU (2) RU2120796C1 (fi)
YU (1) YU48469B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4227479A1 (de) * 1992-08-20 1994-02-24 Dresden Arzneimittel Verfahren zur Herstellung von 1-unsubstituierten 3-Aminopyrrolen
US5792778A (en) * 1995-08-10 1998-08-11 Merck & Co., Inc. 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
US5837719A (en) * 1995-08-10 1998-11-17 Merck & Co., Inc. 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
WO1997016441A1 (en) * 1995-10-31 1997-05-09 Merck & Co., Inc. Substituted aryl pyrroles, compositions containing such compounds and methods of use
US5908858A (en) 1996-04-05 1999-06-01 Sankyo Company, Limited 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
DE19629976A1 (de) * 1996-07-25 1998-01-29 Dresden Arzneimittel Verwendung von 4-(p-Halogenphenyl)-3-morpholinopyrrol-2-carbonsäuremethylester zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
US5776954A (en) * 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
US7122666B2 (en) 1999-07-21 2006-10-17 Sankyo Company, Limited Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
RU2175844C1 (ru) * 2001-01-24 2001-11-20 Северо-Кавказский научно-исследовательский институт сахарной свеклы и сахара Способ получения пищевого волокна из свекловичного жома
BR0209644A (pt) * 2001-05-15 2004-07-06 Warner Lambert Co Processo de compactação para fabricação de uma forma de dosagem de fenitoìna de sódio
US8247423B2 (en) 2007-07-12 2012-08-21 Tragara Pharmaceuticals, Inc. Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
US9944597B2 (en) 2013-09-16 2018-04-17 The Board Of Regents Of The University Of Texas System Polysubstituted pyrroles having microtubule-disrupting, cytotoxic and antitumor activities and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198502A (en) * 1973-08-22 1980-04-15 Gruppo Lepetit S.P.A. Aminopyrrole derivatives
US4632935A (en) * 1984-05-30 1986-12-30 The Upjohn Company Omega-(hydroxy-, ether and ester)-alkyl-2-amino-cycloalkyl- and cycloalkenyl amides as analgesics
US4748183A (en) * 1986-06-13 1988-05-31 Warner-Lambert Company N-1H-tetrazol-5-yl-2-thiophene carboxamides, N-1H-tetrazol-5-yl-2-pyrrole carboxamides, N-1H-tetrazol-5-yl-2-furan carboxamides, and anti-allergic and anti-inflammatory use thereof

Also Published As

Publication number Publication date
JPH07113015B2 (ja) 1995-12-06
EP0431371A1 (de) 1991-06-12
FI905689L (fi) 1991-05-18
RU2120796C1 (ru) 1998-10-27
YU48469B (sh) 1998-08-14
US5502051A (en) 1996-03-26
JPH03271271A (ja) 1991-12-03
DE59010759D1 (de) 1997-10-16
YU217390A (sh) 1993-05-28
FI905689A0 (fi) 1990-11-16
DD298912A5 (de) 1992-03-19
RU2060991C1 (ru) 1996-05-27
FI102169B (fi) 1998-10-30
HUT56343A (en) 1991-08-28
EP0431371B1 (de) 1997-09-10
ES2108005T3 (es) 1997-12-16
US5684160A (en) 1997-11-04
HU907176D0 (en) 1991-05-28

Similar Documents

Publication Publication Date Title
FI904327A7 (fi) N-substituoitu-4-pyrimidiiniamiineja ja -pyrimidiinidiamiineja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI963283A0 (fi) 4-asemasta heterosyklyylillä substituoituja kinatsoliinijohdannaisia, menetelmiä niiden valmistamiseksi ja niiden käyttö syöpälääkkeinä
FI860559A0 (fi) 11 -fenyl-gonaner, deras framstaellning och dessa innehaollande farmaceutiska preparat.
FI862644A0 (fi) Tiazoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar.
FI100104B (fi) Metallikompleksiyhdisteitä, menetelmä niiden valmistamiseksi ja käyttö menetelmä
FI943570A0 (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
FI922620A7 (fi) Peptidijohdannainen, menetelmä sen valmistamiseksi, sitä sisältävä far maseuttinen valmiste ja menetelmä glaukooman hoitamiseksi
NO922005D0 (no) Farmasoeytiske preparater
FI903215A7 (fi) Heteroaryyliamino- ja heteroaryylioksipyridiiniamiineja ja niihin liittyviä yhdisteitä, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkkeinä
FI901102A0 (fi) Farmaceutiska kompositioner.
FI905510A0 (fi) Nya bensoxazinderivat och dessa innehaollande farmaceutiska blandningar.
FI922454A0 (fi) Peptider och antikroppar som inhiberar integrinligandbindning.
FI900313A7 (fi) Uudet bentsopyraanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
FI900035A0 (fi) Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI891227A0 (fi) Katekolderivat och farmaceutiska preparat som innehaoller dessa.
FI902248A7 (fi) N-heteroaryyli-4-kinoliiniamiineja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI906108A7 (fi) Serotoniiniagonisteja, niiden valmistus ja niitä sisältävät lääkkeet
FI911863A0 (fi) Metylendifosfonsyra och antiinflammatoriskt medel innehaollande denna foerening som aktivkomponent.
FI902850A7 (fi) N-heteroaryylipuriini-6-amiineja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina
FI102169B1 (fi) 3-aminopyrrolit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina
FI874020A0 (fi) Tetrahydrokinolinderivat, foerfarande foer deras framstaellning, deras anvaendning och dessa innehaollande farmaceutiska preparat.
FI913100A7 (fi) Farmaseuttiset valmisteet
FI970095A0 (fi) Uudet kemialliset yhdisteet, niiden valmistus ja niiden käyttö lääkeaineena
FI892344L (fi) 6-fenyl-3-piperazinylalkyl-1h,3h -pyrimidin-2-4-dionderivat, deras framstaellning och deras terapeutiska anvaendning.
FI960316A0 (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ARZNEIMITTELWERK DRESDEN GMBH